Latest Breaking News On - Markus warmuth - Page 1 : comparemela.com

Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference

Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMonte rosaMonte rosa quAndrew funderburkCory trombleeMarkus warmuthMonte rosa therapeutics incRosa therapeuticsJefferies global healthcareChief executive officerJefferies global healthcare conferenceEngineered elimination

Monte Rosa Therapeutics Announces Leadership Team Promotions

Monte Rosa Therapeutics Announces Leadership Team Promotions
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesPhil nicksonAndrew funderburkCory trombleeMarkus warmuthJennifer champouxMonte rosa quMonte rosaSharon townsonUniversity of manchester institute technologyIndiana universityNovartis institutes for biomedical researchMonte rosa therapeutics incSuffolk universityMomenta pharmaceuticals

Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease

MRT-6160, a VAV1-directed molecular glue degrader , inhibits colitis disease progression and colon inflammation, lowers inflammatory mucosal cytokines, and reduces expression of IBD-associated genes.

United statesCory trombleeMonte rosaAndrew funderburkMarkus warmuthMonte rosa quMarisa pelusoExchange commissionCompany quCompany mgdsGlobenewswire incMonte rosa therapeutics incRosa therapeuticsDigestive disease weekT andb cellChief executive officer

Monte Rosa Therapeutics : DDW 2024 – MRT 6160, a VAV1 Directed Molecular Glue Degrader, Inhibits Disease Progression in a T cell Transfer Mediated Colitis Model Concomitant with Reduced Calprotectin Expression

#Tu1727: MRT-6160, a VAV1-Directed Molecular Glue Degrader, Inhibits Disease Progression in a T-cell Transfer Mediated Colitis Model Concomitant with Reduced Calprotectin.

United statesJohn castleSharon townsonMarkus warmuthElisa liardoXudong wangShailee voraLaura mcallisterMary zlotoschDaniel lamEswar krishnanBowen wallaceChris kingAlison patersonFilip jankuBradley demarco

Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMarkus warmuthCory trombleeAndrew funderburkMonte rosaMonte rosa quMonte rosa therapeutics incCompany quEuropean alliance of associationsExchange commission onCompany mgdsDevelopment rd expensesAmerican association for cancer researchDrug administrationRosa therapeutics announces first quarterProvides corporate